0001104659-24-063414.txt : 20240520
0001104659-24-063414.hdr.sgml : 20240520
20240520161527
ACCESSION NUMBER: 0001104659-24-063414
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240516
FILED AS OF DATE: 20240520
DATE AS OF CHANGE: 20240520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hochman David P
CENTRAL INDEX KEY: 0001292834
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39421
FILM NUMBER: 24964650
MAIL ADDRESS:
STREET 1: 15 WESTON HILL RD.
CITY: RIVERSIDE
STATE: CT
ZIP: 06878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchestra BioMed Holdings, Inc.
CENTRAL INDEX KEY: 0001814114
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
BUSINESS PHONE: 646-343-9298
MAIL ADDRESS:
STREET 1: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
FORMER COMPANY:
FORMER CONFORMED NAME: Health Sciences Acquisitions Corp 2
DATE OF NAME CHANGE: 20200603
4
1
tm2414952-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-16
0
0001814114
Orchestra BioMed Holdings, Inc.
OBIO
0001292834
Hochman David P
C/O ORCHESTRA BIOMED HOLDINGS, INC.
150 UNION SQUARE DRIVE
NEW HOPE
PA
18938
1
1
0
0
See Remarks
0
Common Stock, par value $0.0001 per share ("Common Stock")
2024-05-16
4
A
0
2000
4.75
A
329502
I
By the DPH 2008 Trust
Common Stock
2024-05-17
4
A
0
3000
5.15
A
332502
I
By the DPH 2008 Trust
Common Stock
3140
I
By the NSH 2008 Family Trust
Common Stock
565498
D
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.74 to $4.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.92 to $5.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Chief Executive Officer and Chairperson
/s/ Matthew R. Schob, Attorney-in-Fact
2024-05-20